La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Sinocare Gestione

Gestione criteri di controllo 4/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Shao Bo Li

Amministratore delegato

CN¥326.1k

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	22yrs
Proprietà del CEO	25.8%
Durata media del management	16yrs
Durata media del Consiglio di amministrazione	4.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Shao Bo Li (59 yo)

22yrs

Mandato

CN¥326,100

Compensazione

Mr. Shao Bo Li serves as the Chairman and General Manager at Sinocare Inc. since August 07, 2002.

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Shao Bo Li	Chairman & GM	22yrs	CN¥326.10k	25.76% CN¥ 3.4b
Shi Min Wang	Deputy General Manager	16yrs	CN¥318.40k	0.14% CN¥ 18.1m
Jianwen Cai	Deputy General Manager	3.8yrs	CN¥2.27m	Nessun dato
Baishen Ouyang	Chairman of the Supervisory Board & Assistant to the GM	no data	Nessun dato	Nessun dato
Chungeng Chen	Supervisor & Supply Chain Director	no data	Nessun dato	Nessun dato

16.0yrs

Durata media

50yo

Età media

Gestione esperta: Il team dirigenziale di 300298 è esperto e expertise (durata media dell'incarico 16 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Shao Bo Li	Chairman & GM	22yrs	CN¥326.10k	25.76% CN¥ 3.4b
Baishen Ouyang	Chairman of the Supervisory Board & Assistant to the GM	7.7yrs	Nessun dato	Nessun dato
Chungeng Chen	Supervisor & Supply Chain Director	6.3yrs	Nessun dato	Nessun dato
Hong Yuan	Independent Director	4.7yrs	CN¥120.00k	Nessun dato
Hongjing Che	Non-Independent Director	8.9yrs	CN¥120.00k	0.051% CN¥ 6.7m
Hui Li	Non-Independent Director	4.7yrs	CN¥120.00k	Nessun dato
Xixiong Kang	Independent Director	4.7yrs	CN¥120.00k	Nessun dato
Jizheng Chen	Independent Director	1.7yrs	CN¥120.00k	Nessun dato
Xinyi Li	Vice Chairman	1.7yrs	CN¥565.40k	Nessun dato

4.7yrs

Durata media

48yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 300298 sono considerati esperti (durata media dell'incarico 4.7 anni).

Sinocare Gestione

Gestione criteri di controllo 4/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Sinocare Inc., Annual General Meeting, May 21, 2024

Sinocare Inc. Approves Board Elections

High number of new directors

Sinocare Inc., Annual General Meeting, May 13, 2022

Recent updates

Sinocare Inc.'s (SZSE:300298) Price Is Out Of Tune With Earnings

Calculating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)

Sinocare Inc. to Report First Half, 2024 Results on Aug 29, 2024

Sinocare Inc. Announces Dividend Implementation for 2023, Payable on 17 June 2024

Is Sinocare (SZSE:300298) A Risky Investment?

Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture

Price target decreased by 8.0% to CN¥31.01

Sinocare Inc., Annual General Meeting, May 21, 2024

Sinocare Inc. Proposes Final Dividend for 2023

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.12 in 1Q 2023)

Investor sentiment improves as stock rises 16%

Sinocare Inc.'s (SZSE:300298) P/E Is On The Mark

Now 21% undervalued after recent price drop

Here's What To Make Of Sinocare's (SZSE:300298) Decelerating Rates Of Return

Sinocare Inc. to Report Q1, 2024 Results on Apr 26, 2024

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

Sinocare Inc. to Report Fiscal Year 2023 Results on Apr 26, 2024

Investor sentiment improves as stock rises 24%

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.28 in 3Q 2022)

Now 20% undervalued

Sinocare Inc. to Report Q3, 2023 Results on Oct 24, 2023

Now 20% undervalued after recent price drop

Price target decreased by 14% to CN¥33.71

Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.26 in 2Q 2022)

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 17%

Sinocare Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 26 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to CN¥39.34

Sinocare Inc. Approves Board Elections

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.14 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.13 in 2Q 2021)

Sinocare Inc. Approves Cash Dividend for the Year 2021

Investor sentiment improved over the past week

Consensus forecasts updated

Price target decreased to CN¥20.73

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Sinocare Inc., Annual General Meeting, May 13, 2022

Sinocare Inc. Proposes Cash Dividend for 2021

Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.16 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.17 in 2Q 2020)

Price target decreased to CN¥40.66

Consensus forecasts updated

First quarter 2021 earnings released: EPS CN¥0.079 (vs CN¥0.11 in 1Q 2020)

Investor sentiment deteriorated over the past week

New 90-day low: CN¥31.87

Sinocare Inc. to Report Fiscal Year 2020 Results on Apr 17, 2021

New 90-day high: CN¥46.30

Third quarter earnings released

Sinocare Inc. to Report Q3, 2020 Results on Oct 17, 2020

Earnings released

Sinocare Inc. to Report First Half, 2020 Results on Aug 07, 2020

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media